Strong association between APOA5 gene polymorphisms and hypertriglyceridaemic episodes

Title:

Strong association between APOA5 gene polymorphisms and hypertriglyceridaemic episodes

Creator:

Vrablik, M., Hubacek, J. A., Dlouha, D., Satny, M., Adamkova, V., and Ceska, R.

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:1ab79a67-fc70-4c05-9b02-665128fd91d6
uuid:1ab79a67-fc70-4c05-9b02-665128fd91d6

Subject:

triglycerides, apoa5, gene polymorphism, and prediction

Type:

model:article and TEXT

Format:

bez média and svazek

Description:

Plasma triglyceride (TG) levels represent a significant risk factor of cardiovascular and total mortality. Concentrations of TG in the plasma depend, to a large extent, on the genetic background, and the apolipoprotein A5 (APOA5) gene seems to be one of the most powerful players in the plasma TG metabolism regulation. In total, we analysed three tagging APOA5 (rs964184, rs662799, rs3135506) SNPs in 209 patients with plasma TG levels over 10 mmol/l (HTG) on at least one occasion and in 379 treatment-naïve controls (NTG) with plasma TG values within the normal range. Minor alleles of all three analysed APOA5 polymorphisms significantly (all P < 0.0001) increased the risk of hypertriglyceridaemia. The most significant association (P < 0.0000001) was observed for the rs964184 polymorphism, where the minor GG homozygotes had the odds ratio (OR, 95% CI) for hypertriglyceridaemia development 21.30 (8.09-56.07, P < 0.000001) in com-arison with the major CC allele homozygotes. Carriers of at least one minor allele at rs3135506 had OR (95% CI) 4.19 (2.75-6.40); (P < 0.000005) for HTG development and similarly, carriers of a minor allele at rs662799 had OR (95% CI) 3.07 (2.00-4.72); (P < 0.0001). The cumulative presence of risk alleles (unweighted gene score) significantly differed between patients with episodes of high TG and controls at P < 0.0000001. There were 73 % of subjects without any of the risk alleles among the controls and 46 % in the patients. In contrast, the controls just included 3 % of subjects with score 3 and more in comparison with 18 % in HTG patients. We conclude that common APOA5 variants are very important genetic determinants of episodic hypertriglyceridaemia in the Czech population with a high potential to be applied in pe-sonalized medicine. and Corresponding author: Michal Vrablík

Language:

English

Rights:

http://creativecommons.org/publicdomain/mark/1.0/
policy:public

Coverage:

[188]-194

Source:

Folia biologica | 2019 Volume:65 | Number:4

Harvested from:

CDK

Metadata only:

false